ASXL1 and B-cell chronic lymphocytic leukemia: Although olaparib treatment did not exert any notable effect on TCL1 CLL cells, it significantly induced apoptosis and reduced the number of Asxl1−/−Ezh2−/− CLL cells (Figure 4F; supplemental Figure 4I).